The use of antihypertensive drugs in the treatment of essential hypertension at outpatient installations, Puskesmas Karang Rejo, Tarakan

Salma Nara Fadhilla, Dharma Permana

Abstract


Background: Essential hypertension is the most common type of hypertension, affecting 95% of hypertensive patients. Essential hypertension can be managed through a combination lifestyle changes and antihypertensive drugs. The aim of this study was to know the use of antihypertensive drugs in the treatment of essential hypertensive at outpatient installations, Puskesmas Karang Rejo, Tarakan.

Methods: The research method is descriptive by using secondary data from complete patient medical records of the essential hypertension patients undergoing outpatient treatment at Puskesmas Karang Rejo, Tarakan in the period of January-April 2017.

Results: A total of 557 medical records were selected, there were 72.53% (n = 404) female and 27.47 % (n = 153) male; age ranged from 20-80 years (mean = 50.32 years). The most common of essensial hypertension were 47.22 % (n = 263) grade II hypertension and 45.42 % (n = 253) grade I hypertension. The antihypertensive drugs were used single or in combination in the following order: Amlodipine (Calcium channel blockers), Captopril (ACE inhibitors), Hydrochlorothiazide/HCT (Diuretic), Methyldopa (alpha-2 adrenergic receptor agonist) and Isosorbid dinitrate (Vasodilator). Four hundred fifty four (81.51%) patients were treated with a single drug (monotherapy) and 103 (18.49%) patients were given combination therapy. Monotherapy and the combination of two antihypertensive drugs were used for prehypertension, grade I hypertension and grade II hypertension, with the most widely used drugs as monotherapy was amlodipine (67.86%, n =378 ) and the mostly used combination therapy of two antihypertensive drugs was Amlodipine-Hydrochlorothiazide (15.80%, n = 88).  The combination of antihypertensive Amlodipin-Hydrochlorothiazide-Captopril (0.35%, n=2) was used for hypertension grade II.

Conclusion: Amlodipine was the most widely used drug as monotherapy or combination drugs therapy in the treatment of essensial hypertension at outpatient installations, Puskesmas Karang Rejo.


Keywords


Essential hypertension, Antihypertensive Drugs and Puskesmas

Full Text:

PDF

References


Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. 2013. Riset Kesehatan Dasar 2013. Jakarta: Kementerian Kesehatan RI. (p: 88 – 90).

Baharuddin, Kabo P dan Suwandi D, 2013. Perbandingan efektifitas dan efek samping Obat Anti Hipertensi terhadap Penurunan Tekanan Darah Pasien. Master Tesis Program Biomedik, Universitas Hasanudin.

Benjamin EJ, Blaha MJ, Chiuve SE, et al, for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2017. Heart disease and stroke statistics-2017 update: a report from American Heart Association. Circulation. 135 (10):e146-e603.

Carretero OA and Oparil S. 2000. Essential hypertension. Part I: definition and etiology. Circulation. 101 (3): 329–35.

Chobanian AV, et al. 2003. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (6): 1206–52.

Dinas Kesehatan Provinsi Kalimantan Utara. 2016. Profil Kesehatan Provinsi Kalimantan Utara. Tanjung Selor: Dinas Kesehatan Provinsi Kalimantan Utara.

Egan BM et al. 2012. Initial Monotherapy and Combination Therapy and Hypertension Control the First Year. Hypertension. 59:1124-1131.

Fitrinto H, Azmi S, Kadri H. 2014. Penggunaan Obat Antihipertensi pada Pasien Hipertensi Esensial di Poliklinik Ginjal Hipertensi RSUP DR. M. Djamil Tahun 2011. Jurnal Kesehatan Andalas 3(1) : 45 – 48.

Fisher ND, Williams GH. 2005. "Hypertensive vascular disease". Di Kasper DL, Braunwald E, Fauci AS et al. Harrison's Principles of Internal Medicine (16th ed.). New York, NY: McGraw-Hill. pp. 1463–81.

Gudmundsdottir H, et al. 2012. Hypertension in women: latest findings and clinical implications. Therapeutic Advances in Chronic Disease 3(3): 137 –146.

Gradman AH et al. 2010. Combination therapy in hypertension. Journal of the American Society of Hypertension 4(1), 42–50.

Julius S et al . 2006. Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker. New Engl J Med 354:1685- 97.

James, Paul A, et al. 2013. "2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults". JAMA. 311 (5): 507–20.

Lackland DT, Weber MA. 2015. "Global burden of cardiovascular disease and stroke: hypertension at the core". The Canadian journal of cardiology. 31 (5): 569–71.

Lee, Hyun-Sook, Lee, Myoungsook, Hyojee, J. (2007). Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. Asian Pacific. Journal of Clinical Nutrition, 16 (1), 10.

Messerli, F. H, Williams, B, Ritz, E. (2007). "Essential hypertension : The Lancet". Lancet. 370 (9587): 591–603.

Muchtar NR, Tjitrosantoso H dan Bodhi W. 2015. Studi penggunaan obat antihipertensi bagi pasien gagal ginjal kronik yang menjalani perawatan di RSUP Prof Dr. R.D Kandou Manado periode juli 2013 – Juni 2014. Pharmacon Vol 4, No. 3, 22-28.

Nafrialdi. 2012. “Antihipertensi”. Farmakologi dan Terapi Edisi 5. Jakarta: Departemen Farmakologik dan Terapeutik Fakultas Kedokteran Universitas Indonesia. (p: 341 – 360).

Oparil S, Zaman MA, Calhoun DA (November 2003). "Pathogenesis of hypertension". Ann. Intern. Med. 139 (9): 761–76.

Pangaribuan, L., & Lolong, D. B. 2015. “Hubungan penggunaan kontrasepsi pil dengan kejadian hipertensi pada wanita usia 15-49 tahun di Indonesia tahun 2013 (analisis data riskesdas 2013)”. Media Penelitian dan Pengembangan Kesehatan, 25(2), 89-96.

Santosa LHK, et al. 2016. Faktor Risiko Kejadian Hipertensi di Puskesma Kendurian, Tuban . Jurnal Kedokteran Diponegoro ,Vol 5 (4), 1182-1191.

Sibai, B.M., 1996.Treatment of Hypertension in Pregnant Women. The New England Journal of Medicine, Vol 335, 257-265

Tandililing S, Mukaddas A, Faustine I. 2017. “Profil Penggunaan Obat Pasien Hipertensi Esensial di Instalasi Rawat Jalan Rumah Sakit Umum Daerah I Lagaligo Kabupaten Luwu Timur Periode Januari – Desember Tahun 2014”. Galenika Journal of Pharmacy. Vol. 3 (1) : 49 – 56.

Tedjasukmana P. 2012. “Tatalaksana Hipertensi”. Cermin Dunia Kedokteran 192, vol. 39 no. 4. pp 251 – 255.

Ulfa NM, Prasetya RA, Adelia L. 2018. Profil Penurunan Tekanan Darah pada Terapi Obat Antihipertensi Golongan CCB Dihidropiridin Antara Amlodipin Dibandingkan Nifedipin Oral Osmotik. Journal of Pharmacy and Science Vol. 3, No.1, 34 – 39.

Williams B et al. 2018. 2018 ESH-ESC Guidelines for the Management of Arterial Hypertension. European Heart Journal, Volume 39, Issue 33, 3021–3104.


Refbacks

  • There are currently no refbacks.


Publisher :
Department of Pharmacology
Faculty of Medicine, Yarsi University,
Jakarta 10510

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.